Table 2. Comparison of clinical data among four groups.

Parameters	BA	NHS	Hyperbilirubinemia	Normal	Significance
N	30	31	32	31
Male	17	21	14	15	N.S.1
Female	13	10	18	16
Age at presentation(d)
mean	58.5	54.8	11.1a	46.5	<0.052
sd	27.5	21.8	7.8	14.8
range	25–120	25–150	3–38	19–81
Weight at presentation (kg)
mean	4.6	4.5	3.4 a	4.4	<0.052
sd	1.0	1.3	0.6	0.8
TB(µmol/l)
mean	163.0b	137.1b	283.2a	26.6	<0.052
sd	57.5	85.8	54.4	25.9
DB(µmol/l)
mean	112.9b	97.5b	19.8	6.4	<0.052
sd	39.0	64.1	16.0	4.8
ALT(U/L)
mean	150.8b	205.2b	16.2	23.1	<0.052
sd	87.6	122.9	7.0	9.8
AST(U/L)
mean	241.1b	286.0b	50.7	41.3	<0.052
sd	125.5	250.4	30.9	18.9
γ-GT (U/L)
mean	552.5c	277.0b	137.6	81.5	<0.052
sd	353.9	185.7	61.9	69.6
TBA(µmol/l)
mean	116.4b	139.5b	12.7	16.1	<0.052
sd	43.3	99.1	10.8	11.7
ALP(U/L)
mean	507.2b	567.9b	193.9	70.8	<0.052
sd	253. 5	224.5	63.7	12.7

¹χ2-test.

²one-way ANOVA followed by a LSD Test.

^aComparison vs normal group p<0.05.

^bComparison vs hyperbilirubinemia and normal group p<0.05.

^cComparison vs NHS group, hyperbilirubinemia and normal group p<0.05.